A study in patients identifies a nontraditional immune pathway that can cause a severe reaction to anesthetic drugs.

A new set of engineered receptors responds to an FDA-approved drug to provide the most potent chemogenetic toolkit to date.

A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.

The Scripps Research Institute will join forces with the California Institute for Biomedical Research.